Talis Biomedical Corporation (TLIS)

USD 1.6

(6.67%)

Operating Expenses Summary of Talis Biomedical Corporation

  • Talis Biomedical Corporation's latest annual operating expenses in 2023 was 67.18 Million USD , down -44.68% from previous year.
  • Talis Biomedical Corporation's latest quarterly operating expenses in 2024 Q2 was 8.49 Million USD , up 7.0% from previous quarter.
  • Talis Biomedical Corporation reported a annual operating expenses of 110.4 Million USD in annual operating expenses 2022, down -42.44% from previous year.
  • Talis Biomedical Corporation reported a annual operating expenses of 191.81 Million USD in annual operating expenses 2021, up 110.36% from previous year.
  • Talis Biomedical Corporation reported a quarterly operating expenses of 8.49 Million USD for 2024 Q2, up 7.0% from previous quarter.
  • Talis Biomedical Corporation reported a quarterly operating expenses of 14.02 Million USD for 2023 Q4, down -17.68% from previous quarter.

Annual Operating Expenses Chart of Talis Biomedical Corporation (2023 - 2018)

Historical Annual Operating Expenses of Talis Biomedical Corporation (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 67.18 Million USD -44.68%
2022 110.4 Million USD -42.44%
2021 191.81 Million USD 110.36%
2020 91.18 Million USD 241.53%
2019 26.69 Million USD 24.59%
2018 21.43 Million USD 0.0%

Peer Operating Expenses Comparison of Talis Biomedical Corporation

Name Operating Expenses Operating Expenses Difference
Acutus Medical, Inc. 11.22 Million USD -498.592%
Biotricity, Inc. 17.18 Million USD -290.967%
Cell MedX Corp. 313.43 Thousand USD -21335.727%
Dynatronics Corporation 9.9 Million USD -578.097%
Nemaura Medical Inc. 7.13 Million USD -841.138%
PetVivo Holdings, Inc. 11.36 Million USD -491.381%
RetinalGenix Technologies Inc. 2.08 Million USD -3119.187%
Sonendo, Inc. 68.46 Million USD 1.868%
Telesis Bio, Inc. 63.48 Million USD -5.823%
Viveve Medical, Inc. 22.17 Million USD -203.008%